Concepedia

Malissa Diehl

MD

Statistics

Publications

10

Citations

643

H-Index

10

Active since

2009

Affiliations

Inovio Pharmaceuticals (United States)(Current)

University of Pennsylvania

The Wistar Institute

Hospital of the University of Pennsylvania

Alliance for Multispecialty Research (United States)

Malissa Diehl is an author at Inovio Pharmaceuticals (United States) specializing in immunology, serious adverse events, and dna vaccines.

Publications per year

2009–2022

10

Publications

10

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 282 citations · Full text

, , +17

Tolerability of intramuscular and intradermal delivery by CELLECTRA<sup>®</sup>adaptive constant current electroporation device in healthy volunteers

Malissa Diehl, Jessica C. Lee, Stephen E. Daniels et al. · Human Vaccines & Immunotherapeutics · 2013 · 93 citations · Full text

, , +17

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes et al. · The Journal of Infectious Diseases · 2022 · 61 citations · Full text

, , +17

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen, Pablo Tebas, Joseph Agnes et al. · medRxiv · 2021 · 43 citations · Full text

, , +17

Elevated TRF2 in advanced breast cancers with short telomeres

Malissa Diehl, Michael O. Idowu, Katherine N. Kimmelshue et al. · Breast Cancer Research and Treatment · 2010 · 40 citations · Full text

, , +14

1–5 of 10